Family Medicine · Beattyville, KY
NPI
1699071480
Since 2011
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1027 Hwy 11 North
Beattyville, KY, 41311
Phone (606) 464-0061
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
18,287 prescriptions
Company payments, 2025
$523
From 8 companies
Medicare prescription drug claims, 2024
In 2024, the drug William J Gay prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 675 prescriptions and refills. In total William J Gay wrote 18,287 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 675 | 675 | 115 | $11K |
| Atorvastatin Calcium Generic | 638 | 1,198 | 148 | $2,599 |
| Gabapentin Generic | 583 | 591 | 87 | $4,703 |
| Omeprazole Generic | 583 | 1,040 | 121 | $2,775 |
| Losartan Potassium Generic | 552 | 1,065 | 115 | $2,499 |
| Levothyroxine Sodium Generic | 549 | 986 | 110 | $3,740 |
| Montelukast Sodium Generic | 513 | 888 | 120 | $2,142 |
| Amlodipine Besylate Generic | 438 | 827 | 109 | $899 |
| Lisinopril Generic | 404 | 782 | 89 | $1,278 |
| Clonazepam Generic | 332 | 340 | 57 | $646 |
| Furosemide Generic | 329 | 541 | 93 | $557 |
| Pantoprazole Sodium Generic | 267 | 501 | 63 | $1,649 |
| Metformin Hcl Generic | 260 | 497 | 61 | $846 |
| Levocetirizine Dihydrochloride Generic | 252 | 462 | 65 | $1,091 |
| Tamsulosin Hcl Generic | 246 | 490 | 57 | $2,493 |
Brand drugs: 2,381 claims; generic drugs: 15,801 claims; opioid claims: 982.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William J Gay $523 ($523 in general payments such as food, travel and fees) from 8 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $158.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 12 | $158 |
| GlaxoSmithKline, LLC. GSK | 4 | $95.54 |
| Abbvie Inc. ABBV | 5 | $80.62 |
| Amgen Inc. AMGN | 4 | $65.98 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $56.35 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $38.6 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $14.19 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $14.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.